RN7SL15P

Across TCGA pan-cancer cohorts, RN7SL15P RNA is linked to patient survival in 13 of 34 cancer types, making it the most broadly survival-associated RN7SL15P data layer.

The strongest signal is observed in thyroid carcinoma (THCA), where higher RN7SL15P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RN7SL15P expression acts as an unfavorable survival marker, although some lineages such as UCEC and SKCM show a favorable association.

THCA, UCEC, and SKCM are the cancer types where RN7SL15P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
THCA	DFS	Median	II,III,IV	0.857	0.950	.002	27	view →
UCEC	OS	Tertile	IV	0.615	0.233	.024	18	view →
SKCM	OS	Median	III,IV	0.861	0.763	.003	13	view →
ESCA	OS	Median	IV	0.222	0.698	.006	12	view →
KIRC	OS	Quartile	All	0.554	0.720	.011	8	view →
THYM	DFS	Quartile	II,III,IV	1.000	0.620	.006	6	view →
LAML	DFS	Tertile	All	0.664	0.460	.033	6	view →
CHOL	DFS	Median	II,III,IV	0.708	0.220	.049	3	view →
READ	DFS	Tertile	IV	1.000	0.204	.038	3	view →
ACC	DFS	Quartile	III,IV	0.951	0.565	.024	3	view →
COAD	DFS	Quartile	All	0.374	0.611	.040	3	view →
TGCT	DFS	Quartile	All	0.907	0.536	.016	2	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 13 lineages.

RN7SL15P–THCA (DFS)

Open the THCA breakdown →